PODD

Insulet Corporation NASDAQ

Healthcare ·Medical - Devices ·US · insulet.com

$171.39

Mkt Cap $11.9B

52w Low $158.35 6.6% of range 52w High $354.88

50d MA $215.79 200d MA $282.05

P/E (TTM) 49.9x

EV/EBITDA 34.6x

P/B 8.1x

Debt/Equity 0.7x

ROE 16.3%

P/FCF 52.9x

RSI (14) —

ATR (14) —

Beta 1.47

50d MA $215.79

200d MA $282.05

Avg Volume 997.4K

About

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distrib…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 18, 2026	AMC	1.47	1.55	+5.4%	258.07	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%	-12.0%	—
Nov 6, 2025	AMC	1.14	1.24	+8.8%	323.40	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%	-8.4%	—
Aug 7, 2025	AMC	0.92	1.17	+27.2%	303.55	+0.0%	+1.2%	+0.4%	+2.0%	+1.7%	+4.0%	+15.2%	—
May 8, 2025	AMC	0.79	1.02	+29.1%	257.00	+14.0%	+20.9%	+23.2%	+22.4%	+25.1%	+25.3%	+18.9%	—
Feb 20, 2025	AMC	1.00	1.15	+15.0%	288.29	-4.1%	-1.9%	-1.7%	-7.5%	-6.1%	-7.4%	-4.9%	—
Nov 7, 2024	AMC	0.76	0.90	+18.4%	244.98	+4.9%	+9.4%	+12.5%	+12.3%	+9.8%	+6.6%	+8.2%	—
Aug 8, 2024	AMC	0.56	0.55	-2.5%	199.79	-12.8%	-8.8%	-5.9%	-2.6%	-4.1%	-2.4%	+9.7%	—
May 9, 2024	AMC	0.39	0.73	+87.2%	177.53	+2.4%	-6.6%	-9.3%	-3.0%	+1.7%	+4.4%	+8.2%	—
Feb 22, 2024	AMC	0.66	1.40	+112.1%	197.14	-6.2%	-6.6%	-14.4%	-15.5%	-17.0%	-16.8%	-16.4%	—
Nov 2, 2023	AMC	0.40	0.71	+77.5%	140.44	+11.1%	+15.8%	+13.2%	+15.3%	+10.3%	+8.9%	+38.1%	—
Aug 8, 2023	AMC	0.26	0.38	+46.2%	238.34	-1.4%	-3.6%	-2.0%	-5.5%	-6.1%	-8.1%	-25.1%	—
May 4, 2023	AMC	0.09	0.23	+155.6%	322.23	+1.2%	+2.0%	-1.0%	-0.8%	+0.2%	-0.3%	-11.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	Rothschild & Co Redburn	Downgrade	Buy → Neutral	$220	$192.21	$188.85	-1.7%	-1.4%	-2.0%	-4.9%	-16.7%	-10.4%
Apr 24	Rothschild & Co	Downgrade	Buy → Neutral	—	$192.21	$188.85	-1.7%	-1.4%	-2.0%	-4.9%	-16.7%	-10.4%
Apr 15	Truist	Maintains	Buy → Buy	—	$201.49	$202.82	+0.7%	+0.5%	-0.0%	+1.1%	-0.3%	-4.5%
Apr 9	Goldman Sachs	Maintains	Buy → Buy	—	$203.51	$201.67	-0.9%	-2.0%	-3.2%	-2.8%	-1.0%	-0.5%
Apr 7	Citigroup	Downgrade	Buy → Neutral	—	$203.50	$200.55	-1.4%	-0.5%	+0.0%	-2.0%	-3.2%	-2.8%
Mar 11	Citigroup	Maintains	Buy → Buy	—	$238.24	$236.85	-0.6%	+0.2%	-0.9%	-7.7%	-5.7%	-3.3%
Feb 19	Canaccord Genuity	Maintains	Buy → Buy	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Truist	Maintains	Buy → Buy	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Oppenheimer	Maintains	Outperform → Outperform	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Bernstein	Maintains	Outperform → Outperform	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Evercore ISI	Maintains	Outperform → Outperform	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Citigroup	Maintains	Buy → Buy	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Goldman Sachs	Maintains	Buy → Buy	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	JP Morgan	Maintains	Overweight → Overweight	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 19	Leerink Partners	Maintains	Outperform → Outperform	—	$258.07	$257.58	-0.2%	-3.5%	-6.3%	-3.4%	-5.0%	-3.9%
Feb 18	BTIG	Maintains	Buy → Buy	—	$246.34	$266.00	+8.0%	+4.8%	+1.1%	-1.8%	+1.2%	-0.4%
Feb 4	Stifel	Maintains	Buy → Buy	—	$251.22	$253.19	+0.8%	+0.0%	-3.2%	-3.7%	-2.2%	+0.5%
Jan 12	Barclays	Downgrade	Equal Weight → Underweight	—	$289.04	$286.71	-0.8%	-3.6%	-3.8%	-2.1%	-0.9%	-0.5%
Jan 9	Bernstein	Maintains	Outperform → Outperform	—	$292.89	$293.08	+0.1%	-1.3%	-4.9%	-5.0%	-3.4%	-2.2%
Dec 18	Truist	Maintains	Buy → Buy	—	$289.57	$292.19	+0.9%	+1.1%	+0.0%	+0.7%	-1.4%	-0.3%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$288.73	$288.81	+0.0%	+0.3%	+1.4%	+0.3%	+1.0%	-1.1%
Nov 24	Canaccord Genuity	Maintains	Buy → Buy	—	$331.17	$330.03	-0.3%	+1.9%	-0.7%	-1.3%	-1.2%	-6.1%
Nov 21	Truist	Maintains	Buy → Buy	—	$312.89	$321.96	+2.9%	+5.8%	+7.9%	+5.1%	+4.4%	+4.6%
Nov 21	BTIG	Maintains	Buy → Buy	—	$312.89	$321.96	+2.9%	+5.8%	+7.9%	+5.1%	+4.4%	+4.6%
Nov 21	RBC Capital	Maintains	Outperform → Outperform	—	$312.89	$321.96	+2.9%	+5.8%	+7.9%	+5.1%	+4.4%	+4.6%
Nov 19	UBS	Upgrade	Neutral → Buy	—	$333.47	$340.24	+2.0%	+3.9%	-6.2%	-0.7%	+1.2%	-1.4%
Nov 13	BTIG	Maintains	Buy → Buy	—	$336.84	$334.87	-0.6%	-1.2%	-1.2%	-2.6%	-1.0%	+2.8%
Nov 7	Canaccord Genuity	Maintains	Buy → Buy	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 7	UBS	Maintains	Neutral → Neutral	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 7	Truist	Maintains	Buy → Buy	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 7	Wells Fargo	Maintains	Overweight → Overweight	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 7	RBC Capital	Maintains	Outperform → Outperform	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$323.40	$326.35	+0.9%	-1.1%	-0.9%	+0.9%	+4.2%	+2.9%
Nov 6	Jefferies	Maintains	Buy → Buy	—	$314.44	$323.49	+2.9%	+2.8%	+1.7%	+1.9%	+3.8%	+7.1%
Nov 5	Barclays	Maintains	Equal Weight → Equal Weight	—	$320.27	$315.23	-1.6%	-1.8%	+1.0%	-0.1%	+0.0%	+1.9%
Sep 29	Canaccord Genuity	Maintains	Buy → Buy	—	$318.00	$319.60	+0.5%	-2.3%	-2.9%	-3.8%	-1.8%	-2.8%
Sep 8	Oppenheimer	Maintains	Outperform → Outperform	—	$348.43	$349.56	+0.3%	+0.3%	+1.3%	-3.1%	-3.0%	-1.9%
Aug 21	Barclays	Maintains	Equal Weight → Equal Weight	—	$333.00	$332.23	-0.2%	-1.5%	-0.7%	-1.2%	-0.4%	+0.4%
Aug 8	RBC Capital	Maintains	Outperform → Outperform	—	$303.55	$303.55	+0.0%	+1.2%	+0.4%	+2.0%	+1.7%	+4.0%
Aug 8	Canaccord Genuity	Maintains	Buy → Buy	—	$303.55	$303.55	+0.0%	+1.2%	+0.4%	+2.0%	+1.7%	+4.0%
Aug 8	Wells Fargo	Maintains	Overweight → Overweight	—	$303.55	$303.55	+0.0%	+1.2%	+0.4%	+2.0%	+1.7%	+4.0%
May 27	Raymond James	Maintains	Outperform → Outperform	—	$321.36	$325.00	+1.1%	+1.6%	+0.7%	+0.8%	+1.1%	+1.1%
May 22	Citigroup	Maintains	Buy → Buy	—	$324.50	$324.00	-0.2%	-1.1%	-1.0%	+0.7%	-0.3%	-0.2%
May 13	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$316.67	$316.67	+0.0%	-0.7%	+1.5%	+1.7%	+2.6%	+2.9%
May 9	Oppenheimer	Maintains	Outperform → Outperform	—	$257.00	$293.03	+14.0%	+20.9%	+23.2%	+22.4%	+25.1%	+25.3%
Apr 30	Barclays	Maintains	Equal Weight → Equal Weight	—	$251.27	$249.55	-0.7%	+0.4%	-0.4%	+2.3%	+3.0%	+3.0%
Apr 29	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$259.52	$255.65	-1.5%	-3.2%	-2.8%	-3.6%	-1.0%	-0.3%
Feb 21	Citigroup	Maintains	Buy → Buy	—	$288.29	$276.35	-4.1%	-1.9%	-1.7%	-7.5%	-6.1%	-7.4%
Feb 21	Raymond James	Maintains	Outperform → Outperform	—	$288.29	$276.35	-4.1%	-1.9%	-1.7%	-7.5%	-6.1%	-7.4%
Feb 21	Piper Sandler	Maintains	Overweight → Overweight	—	$288.29	$276.35	-4.1%	-1.9%	-1.7%	-7.5%	-6.1%	-7.4%